LEBANON, Ohio, May 22, 2018 /PRNewswire/ -- Palarum LLC announced today it has completed the private placement of $3.8 million of Series 2018-A Convertible Notes, through a Regulation D 506(b) offering to qualified buyers. The Notes are convertible into Units and have a two-year term. The Notes and the Units issuable upon conversion of the Notes have not been
Palarum brought the PalarumPUP™ (Patient is UP), a revolutionary patient sock that incorporates patented technology to help prevent patient falls and enhance rehabilitation therapy, to the healthcare market in 2017. Using eTextile and IoT technologies, PUP™ patient socks issue real-time alarms to immediately notify nearby nurses that a patient who has been identified as high-risk for falls is out of bed, standing and/or attempting to walk unassisted. Currently, several hospitals around the country are evaluating the effectiveness of the sock among its patient population.
This notice shall not constitute an offer to sell or the solicitation of an offer to buy the Notes. Palarum LLC headquartered in Lebanon, Ohio is an independent medical technology company. The Company develops and produces mobile platforms, devices and applications which improve patient safety, mobility, and rehabilitation in inpatient, outpatient, and home settings.
Founded in 2016 by the former Chief Nursing Officer of a large community hospital in Lebanon, Ohio, Palarum created the revolutionary PUP™ smart sock that incorporates patented technologies woven into conductive fabric, enabling real-time monitoring to prevent patient falls and enhance physical therapy and rehabilitation. PUP, the most technologically advanced, nurse-centric, patient mobility system in healthcare: improves patient safety by greatly reducing injuries from falls; significantly reduces costs related to falls; decreases alarm fatigue through a smart notification system; and generates critical new data to enhance facility operations. PUP is designed for acute care hospitals, as well as facilities for rehabilitation, long-term care, and physical therapy. www.palarum.com.
View original content:http://www.prnewswire.com/news-releases/palarum-llc-completes-private-placement-of-convertible-notes-300653217.html
SOURCE Palarum LLC
Subscribe to our Free Newsletters!
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...View All